ENTITY

Soligenix (SNGX US)

20
Analysis
Health Care • United States
Soligenix, Inc. develops therapeutics and vaccines. The Company researches treatments for gastrointestinal Graft-versus-Host disease and cancer, and develops vaccines for military and civilian applications.
more
Exchange Announcement • 19 Nov 2025 05:05
Exchange Announcement • 08 Nov 2025 05:12
Exchange Announcement • 08 Nov 2025 05:10
Exchange Announcement • 08 Nov 2025 05:09
Exchange Announcement • 08 Nov 2025 05:06
x